Status:
WITHDRAWN
Virtual Overdose Response
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Alberta Innovates Health Solutions
AHS Addiction and Mental Health Strategic Clinical Network
Conditions:
Drug Overdose
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To help prevent deaths in populations that cannot or will not access physical safer consumption services in Alberta, which may disproportionately include women and those who are not able to self-injec...
Detailed Description
Designed as a small open label clinical study to demonstrate proof of concept which will follow CONSORT guidelines, the investigators aim to recruit approximately 15 people who are currently using ill...
Eligibility Criteria
Inclusion
- Able to give informed consent - able to speak and understand English and over 18 years of age
- Admit to using opioids non-medically: using illicit opioids; using prescription opioids without a current prescription; using doses greater than those prescribed; using opioids recreationally
- Have access to a phone line in the location they primarily use opioids: this can be a land line or a cell phone
- Resident of Calgary
Exclusion
- Unable to give informed consent - unable to understand English, under 18 years of age or otherwise not legally able
- Do not knowingly use opioids non-medically
- No access to a phone
- Live outside of Calgary
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04391192
Start Date
September 1 2020
End Date
February 1 2021
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Undetermined
Calgary, Alberta, Canada